Potential for treatment with thrombolysis in an Irish stroke unit

Irish Medical Journal

Volumn 92, Issue 1, 1999, Pages 236-238

  Collins, D R ^a   O'Neill, D ^a   Mccormack, P M E ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; FEMALE; HUMAN; HYPERTENSION; IRELAND; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CEREBRAL INFARCTION; CEREBROVASCULAR DISORDERS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; HYPERTENSION; IRELAND; MALE; MIDDLE AGED; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0032619252     PISSN: 03323102     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. McDonnell B. HIPE data on stroke in EHB region (presentation). First national meeting of The Stroke Council of The Irish Heart Foundation May 1998.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue Plasminogen Activator for Acute Ischaemic Stroke. N Engl J Med. 1995:333: 1581-1587.
3. Stroke Unit Trialists Collaboration. Collaborative Systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. BMJ; 1997:314:1 151-1159.
4. International Stroke Trial Collaborative Group. The International Stroke Trial (1ST): a randomised trial of aspirin , subcutaneous hepatin, both ,or neither among 19,435 patients with acute ischaemic stroke. Lancet 1997; 349:1569-1581.
5. Special Writing Group of the Stroke Council, American Heart Association. Guidelines for Thrombolytic Therapy for Acute Ischaemic Stroke: A supplement to the guidelines for the management of patients with acute ischaemic stroke. Stroke 1996; 27:1711-1718.
6. Meyer JS, Gilroy J, Barnhart ME, Johnson JF. Therapeutic thrombolysis in cerebral thromboembolism: randomised evaluation of intravenous streptokinase. In: Millikan CH, Siekert RG, Whisnat JP, eds. Cerebral Vascular Diseases, Fourth Princeton Conference. New York: Grune and Stratton, 1965: 200-213.
7. Hanaway J, Torack R, Fletcher AP, Landau, WM, Intracranial bleeding associated with Urokinase therapy for acute ischaemic hemispheric stroke. Stroke 1976;. 7:135-142.
8. Del Zoppo GJ, Copeland BR, Waltz TA, Zyroff J, Plow ER Harker LA. The beneficial effect of intracarotid urokinase on acute stroke in the baboon model. Stroke 1986; 17:638-643.
9. Zivin JA, Lyden PD, DeGirolami U, et al. Tissue plasminogen activator: Reduction of neurologic damage after experimental embolic stroke. Arch. Neurol 1988; 45:387-391.
10. Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte PN. Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 1992; 42:289-298.